Abstract
Renovascular hypertension (RVH) is a prevalent cause of secondary hypertension that frequently develops to resistant hypertension. It is characterised as systemic hypertension that develops as a result of a restricted blood supply to the kidneys. Patients cannot be recognized clinically from those with essential hypertension; therefore, diagnosis requires arteriography, however urography and isotope renography may hint to the diagnosis. Atherosclerotic renal artery stenosis (ARAS) and fibromuscular dysplasia are the two most prevalent causes of RVH. The ultimate objective of controlling RVH, like with other kinds of hypertension, is to minimize the morbidity and mortality associated with high blood pressure The widespread use of effective antihypertensive medication treatment, statins, and other strategies to control vascular disease has resulted in remarkable improvements. In this review we will be looking at etiology, pathogenesis and treatment or RVH.
Highlights
In the United States, 75 million people have high blood pressure, which accounts for 8.6% of all primary care visits
Renovascular hypertension (RVH)is a prevalent cause of secondary hypertension that frequently develops to resistant hypertension
It is characterised as systemic hypertension that develops as a result of a restricted blood supply to the kidneys, which is generally caused by an occlusive lesion in the primary renal artery [1]
Summary
In the United States, 75 million people have high blood pressure, which accounts for 8.6% of all primary care visits. Different findings have left both patients and doctors unsure regarding the optimal way to manage renovascular hypertension, in terms of whether endovascular or surgical intervention should be used Because of this "equilibrium" between medical therapy and renal revascularization, the National Institutes of Health (NIH) in the United States is funding a large prospective, randomised trial comparing intensive medical therapy alone to intensive medical therapy plus renal revascularization for Renal Atherosclerotic Lesions [3] The widespread use of effective antihypertensive medication treatment, statins, and other strategies to control vascular disease has resulted in remarkable developments. Renovascular disease has evolved dramatically in the last decade because to advancements in imaging, medicinal management, and renal revascularization procedures This has proven especially true for renal artery stenosis (RAS) caused by atherosclerosis, which is still one of the most prevalent causes of hypertension and can be identified by chance. Medical treatment, which includes renin-angiotensinaldosterone system antagonists, lipid-lowering medicines, and antiplatelet medication, percutaneous angioplasty with or without stent implantation, and surgical revascularization are the three therapeutic options available. [6]
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call